PHAR
Pharming Group N.V.
NASDAQ · Healthcare · Biotechnology · NL
$11.23
−2.01%Forward multiples
Based on analyst estimates
- P/E forward
- 52.77x
- P/E 2026E
- 49.24x
- P/E 2027E
- 42.70x
- P/E 2028E
- 30.78x
- P/S forward
- 2.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- 81.38x
- PEG TTM
- 1.51x
- Price / book
- 2.94x
- Price / sales
- 2.17x
- Price / cash flow
- 24.84x
Enterprise value
- Enterprise value
- $749.9M
- EV / sales
- 2.05x
- EV / EBITDA
- 17.58x
- EV / EBIT
- 60.71x
- Market cap
- $794.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026